Skip to content
Home/Companies/Pharma/Novaliq
Novaliq

Novaliq

Pharma·Germany·Active·19yr hold
Entry
2007
Hold
19yr
Status
Active

Who owns Novaliq?

Novaliq is a German Pharma company, currently owned by dievini Hopp BioTech holding since 2007.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
dievini Hopp BioTech holding
Investor
dievini Hopp BioTech holding
dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen

Key facts

HQGermany
SectorPharma
StatusActive
Websitewww.novaliq.com

More from dievini Hopp BioTech holding (Evergreen Balance Sheet)

Other portfolio companies in the same fund.

Heidelberg Pharma
Heidelberg Pharma
Active
BiotechGermany· 2009
Immatics
Immatics
Active
BiotechGermany· 2006
Apogenix
Active
BiotechGermany· 2005
CureVac
CureVac
Exited 2025
BiotechGermany· 2005
to BioNTech
Molecular Health
Exited 2026
SaaSGermany· 2004

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Novaliq?

Novaliq is currently owned by dievini Hopp BioTech holding, through dievini Hopp BioTech holding (Evergreen Balance Sheet), since 2007.

When did dievini Hopp BioTech holding acquire Novaliq?

dievini Hopp BioTech holding acquired Novaliq in 2007.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue